Literature DB >> 20193588

[Study on cancer incidence through the cancer registry program in 11 cities and counties, China].

Tao Lei1, Wei-min Mao, Hong-jian Yang, Xiao-zhong Chen, Tong-hai Lei, Xiang-hui Wang, Qian Ying, Wan-qing Chen, Si-wei Zhang.   

Abstract

OBJECTIVE: Aim of this paper was to explore the trend and characteristics of cancer incidence in 11 areas (5 cities and 6 counties) in China.
METHODS: Data from cancer registries during 1988 to 2002 collected from the 11 cancer registry points were used to analyze the trends and characteristics of cancer incidence rates.
RESULTS: There were 695 050 newly developed cancer cases in this study. The crude rate of incidence and the world age-adjusted incidence were 215.50/10(5) and 170.97/10(5) respectively. The leading cancer sites were lung, stomach, liver, esophagus, breast, colon, rectum, pancreas, bladder and leukemia. The sixteen key cancers accounted for 85.56% of all the cancer cases. The crude incidence rate of all cancers had been significantly increased from 1988 to 2002. Among them, prostate (185.48%) ranked the fastest growing one followed by cancers of the gallbladder, breast, colon, ovarian, lymphoma, bladder, pancreas, rectum, lung, leukemia and liver. The one that had reduced the most was cervix uteri (17.00%), followed by esophagus, stomach and nasopharynx.
CONCLUSION: Crude cancer incidence rate increased in the 11 areas in China from 1988 to 2002. The ranking of pancreas cancer, bladder cancer and leukemia came into the top ten. Even though the incidence rates of prostate and gallbladder cancer were relative low but had a fast increase. The results of this study provided a scientific base for the development of a better strategy on cancer prevention and control in China.

Entities:  

Mesh:

Year:  2009        PMID: 20193588

Source DB:  PubMed          Journal:  Zhonghua Liu Xing Bing Xue Za Zhi        ISSN: 0254-6450


  11 in total

1.  Breast Cancer Challenges and Screening in China: Lessons From Current Registry Data and Population Screening Studies.

Authors:  Qing-Kun Song; Xiao-Li Wang; Xin-Na Zhou; Hua-Bing Yang; Yu-Chen Li; Jiang-Ping Wu; Jun Ren; Herbert Kim Lyerly
Journal:  Oncologist       Date:  2015-05-22

Review 2.  Clinical application of DNA ploidy to cervical cancer screening: A review.

Authors:  David Garner
Journal:  World J Clin Oncol       Date:  2014-12-10

3.  Reduced expression of MTUS1 mRNA is correlated with poor prognosis in bladder cancer.

Authors:  Jun Xiao; Jun-Xing Chen; Yu-Ping Zhu; Lin-Yu Zhou; Qi-An Shu; Ling-Wu Chen
Journal:  Oncol Lett       Date:  2012-04-05       Impact factor: 2.967

4.  Type 2 diabetes and the risk of non-Hodgkin's lymphoma: a report from two population-based cohort studies in China.

Authors:  Wan-Shui Yang; Hong-Lan Li; Hong-Li Xu; Gong Yang; Yu-Tang Gao; Wei Zheng; Xiao-Ou Shu; Yong-Bing Xiang
Journal:  Eur J Cancer Prev       Date:  2016-03       Impact factor: 2.497

5.  Plasma proteasomal chymotrypsin-like activity correlates with prostate cancer progression.

Authors:  Xiangrong Deng; Ping Zhou; Xinghua Wei; Matthew Uhlman; Yurong Lin; Xuanting Lin; Sifeng Wu; Pengfei Diao; Haiqing Xie; Jinbao Liu; Keji Xie; Ping Tang
Journal:  Tumour Biol       Date:  2015-01-13

6.  Colorectal cancer screening: comparison of transferrin and immuno fecal occult blood test.

Authors:  Ji-Gui Chen; Juan Cai; Huan-Lei Wu; Hua Xu; Yu-Xing Zhang; Chao Chen; Qian Wang; Jun Xu; Xiang-Lin Yuan
Journal:  World J Gastroenterol       Date:  2012-06-07       Impact factor: 5.742

7.  Potential use of chymotrypsin-like proteasomal activity as a biomarker for prostate cancer.

Authors:  Xinghua Wei; Weiwei Zeng; Keji Xie; Pengfei Diao; Ping Tang
Journal:  Oncol Lett       Date:  2018-02-02       Impact factor: 2.967

8.  Co-expression of RAGE and HMGB1 is associated with cancer progression and poor patient outcome of prostate cancer.

Authors:  Chu-Biao Zhao; Ji-Ming Bao; Yong-Jie Lu; Tong Zhao; Xin-Hua Zhou; Da-Yong Zheng; Shan-Chao Zhao
Journal:  Am J Cancer Res       Date:  2014-07-16       Impact factor: 6.166

9.  Lesions of the central nervous system in leukemia: Pathological and magnetic resonance imaging features at presentation in 14 patients.

Authors:  Jing Liu; Yaming Wang; Xuefei Sun; Shuo Liu; Zhenkun Yu; Nan Ji; Shengjun Sun; Yuanbo Liu
Journal:  Oncol Lett       Date:  2017-10-16       Impact factor: 2.967

10.  Epidemiological characteristics of cancer in elderly chinese.

Authors:  Xiao Nong Zou; Xia Wan; Zhen Dai; Gong Huan Yang
Journal:  ISRN Oncol       Date:  2012-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.